Introduction
Cardiac resynchronization therapy (CRT) is established as a treatment modality for selected patients with advanced heart failure (HF).
1,2 With this therapy, improvements in exercise duration, quality of life, and left ventricular (LV) systolic performance are observed, whereas hospitalizations and mortality are reduced. 3 One of the critical problems with CRT is the prospective identification of patients that will benefit. Even though over the years insight into various factors influencing the likelihood of response, such as sex, HF aetiology, electrocardiogram (ECG) characteristics, and lead position have undergone a rapid evolution, 3 30-50% of patients still do not respond to CRT therapy, depending on definition of CRT response. 4 Even in patients who are deemed to have a high chance for response-i.e. patients with non-ischaemic HF, typical left-bundle branch block (LBBB) ECG morphology, and broad QRS complexes-response varies from no improvement to normalization of systolic LV function. Improved predictors are needed to prevent unnecessary implantations with a chance of complications and associated high healthcare costs. Several studies have investigated contractile reserve, a surrogate marker of global myocardial contractility, using visual assessment of the myocardium or changes in LVEF after an inotropic challenge, as predictive factor of positive CRT response. 5 -13 Impaired LV function at rest is not necessarily an irreversible process; the myocardium might present itself with reduced contractility while still viable. Dobutamine is a synthetic catecholamine with direct 1-adrenoceptor agonist effects and additional mild 1-and 2-agonistic properties, and dobutamine stress echocardiography (DSE) is an established tool for detecting myocardial viability. The identification of viable myocardium with dobutamine imaging is based on the principle that whereas global contractile function may be abnormal at rest, improved contractility with inotropic stimulation may differentiate viable (positive contractile reserve) from non-viable, scarred myocardium (negative contractile reserve). Pacing in non-viable myocardium can result in less effective or even ineffective pacing, leading to failure of LV resynchronization and consequently no benefit of CRT.
14 Therefore, using DSE to study the LV performance, in either the true failing heart or the heart with impaired systolic function, may help differentiate irreversible from reversible heart damage and assist physicians in clinical decision-making. In the present paper we systematically reviewed the literature looking at the role of contractile reserve in predicting response to CRT and performed a meta-analysis.
Methods

Data searches and sources
The purpose of this meta-analysis was to evaluate the role of contractile reserve in predicting CRT response. An extensive search of published data in MEDLINE/PubMed, the Cochrane Library, and ClinicalTrials.gov was performed to 26 April 2016, using a combination of words related to contractile reserve and CRT without any restrictions (see the Supplementary material online for search strategy, Methods S1). To identify further potentially relevant studies missed by the electronic database search, reference lists of selected studies were manually screened. Figure 1 illustrates the flow diagram for study selection. Fifty potentially relevant studies were identified. After screening of the abstracts, 16 studies were selected for full-text assessment of which nine fulfilled the inclusion criteria. Studies were included if they: (i) had a clearly stated singular definition that defined the presence or absence of contractile reserve; (ii) included a clear definition that defined CRT response; (iii) performed DSE. Studies were excluded if they: (i) focused on specific populations (e.g. CRT super-responders, patients with aortic stenosis or septal flash, or post-CRT implantation populations); (ii) had a short follow-up period <6 months; (iii) consisted of experimental studies, case reports, case series, reviews, editorials, or conference papers; (iv) had unreliable or incomplete data; (v) were not written in English.
Selection and inclusion of studies
Risk of bias
Papers published by the same research group and studying the same factors were checked for potential duplicate data based on the year of inclusion and hospital of patient recruitment. To avoid double counting of a cohort we used one set of results when multiple publications were available from the same cohort. For the meta-analysis the priority was given to the study with the largest number of patients and/or identical to the other studies (see the Supplementary material online for search strategy, Methods S1).
Quality assessment
Each included study was assessed for internal validity in order to guarantee data consistency and completeness. The quality of selected studies was independently assessed by two authors (M.K., A.H.M.) based on combined criteria suggested by Pai et al. 15 and Wells et al. 16 The studies were assessed across the following metrics: (i) study design; (ii) a focused research question that was adequately formulated and described; (iii) full description of patient population; (iv) data collection (prospective or retrospective); (v) assignment of the patient (consecutive or random); (vi) inclusion criteria; (vii) exclusion criteria; (viii) method quality (description of the dobutamine stress scheme and the measurements performed on echocardiography); (ix) interpretation of factors (description of blinded method/not blinded/no description); (x) complete follow-up present or reasons for missing data explained (see the Supplementary material online for the assessment of study quality, Table S1 ).
Data extraction and management
Data were extracted on study characteristics (first author, year of publication, follow-up duration in days, maximum dobutamine dose, definition of contractile reserve, definition of response to CRT), patient characteristics [demographics (age and sex), medical history (history of ischaemic cardiomyopathy), and clinical data (New York Heart Association class, use of -blockers, diuretics, and angiotensin-converting enzyme inhibitors -ACEi -or angiotensin receptor blockers -ARB)], echocardiographic parameters [left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV)], electrocardiographic (QRS duration) and outcome data (presence of contractile reserve and presence of CRT response) ( Table 1) .
Definition of contractile response and response to cardiac resynchronization therapy
Different definitions of echocardiographic response to CRT were used in the studies but the data could be pooled by using one combined definition: an increase in LVEF of ≥5% and/or a decrease in LVESV of ≥10% after 6 months' follow-up. 17 To determine presence or absence of contractile reserve the studies focused either on a relative (>20%) or absolute (>5%) increase in LVEF during dobutamine infusion compared with the resting condition (n = 4), or an improvement in wall motion score after dobutamine infusion (n = 5). Wall motion score was assessed according to a 16 or 17 segment model of the LV recommended by the American Society of Echocardiography. Segments were scored from normal to dyskinetic. Contractile reserve was defined as delta variation of (rest-stress) ≥0.20 in wall motion score index or an improvement of ≥1 grade in a number of LV segments ( Table 2) .
Titles identified from electronic bibliographies and abstracts screened for retrieval N=50 that represent the odds that a patient with contractile reserve would also have a significant CRT response. Heterogeneity among the results was assessed using standard chi-square test and I 2 statistic for heterogeneity. Diversity in individual study results was analysed using random-effects meta-regression analysis. Study variables investigated in meta-regression were year of publication, total number of patients, follow-up time, gender, age, ischaemic aetiology, LVEF, LVESV, QRS duration, medical therapy (including use of ACEi, ARBs, diuretics, and -blockers), and maximum dobutamine dosage. Possible confounding in studies was assessed by inspection of the funnel plot that indicated possible publication bias. We used the Metatrim command (which uses an imputation method to account for 'missing' studies) to evaluate the asymmetry of the funnel plot and subsequent publication bias.
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Results are presented as ORs with 95% confidence intervals (CIs) and P-values. All reported probability values are two-tailed a P-value of 0.05 was considered statistically significant. Statistical analyses were performed using Stata 12.0 (Stata Corp., College Station, TX, USA) and RevMan 5.1. 19
Results
Study characteristics
All nine included studies were observational studies that enrolled consecutive patients who were candidates for CRT according to the most current guidelines at the time of implantation. The study population and methods for DSE were sufficiently described and . missing data were accounted for. Overall quality of the studies was considered to be consistent and sufficient for both design and report. Overall, 767 patients were included of whom 757 had present echocardiographic data that provided quantitative data for the meta-analysis. The total population consisted of 548 men (71%) and 219 women (29%), and the mean age ranged from 62 to 71 years. The maximum dobutamine dose administered ranged from 10 μg/mL/min to 40 μg/mL/min. A total of 496 patients (66%) had contractile reserve at baseline and 474 patients (63%) showed a response to CRT during follow-up. The presence or absence of contractile reserve and CRT response is depicted in Figure 2 . Characteristics of the studies included are shown in Table 1 .
Meta-analysis of contractile reserve and subsequent response to cardiac resynchronization therapy
The primary outcome was the association between contractile reserve at baseline and CRT response (Figure 3) . The pooled ORs of CRT response for contractile reserve was 4.42 (95% CI 2.15-9.07, P < 0.001) in a random-effects model. The ORs differed slightly when studies were separated based on the definition of contractile reserve. Contractile reserve defined as an increase in LVEF showed 
ICM, ischaemic cardiomyopathy; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association. * A total of 59 patients had present echocardiographic data and were included in the meta-analysis. 5 Decrease in LVESV of ≥15% Relative increase in LVEF of >20% * Chaudhry et al. 6 Increase in LVEF >5% Improvement in contractility in >5 LV segments Ciampi et al. 7 Decrease in LVESV of ≥15% Decrease in WMSI of ≥0.20 Mizia-Stec et al. 8 Decrease in LVESV of ≥15% Decrease in WMSI of ≥0.20 Muto et al. 9 Decrease in LVESV of ≥10% Absolute increase in LVEF of >5% Pugliese et al. 10 Decrease in LVESV of ≥15% and/or increase in LVEF >5%
Decrease in WMSI of ≥0.20
Sénéchal et al. 11 Decrease in LVESV of ≥15% Improvement in contractility in ≥4 LV segments Stankovic et al. 12 Decrease in LVESV of >10% † Absolute increase in LVEF of >5% Tuccillo et al. 13 Decrease in LVESV of ≥15% Relative increase in LVEF of >25% an OR of 3.77 (95% CI 0.77-18.45), for contractile reserve defined as increased contractility the OR was numerically higher, at 5.15 (95% CI 2.59-10.24), but the P-value for heterogeneity was non-significant. There was substantial heterogeneity between the studies (I 2 = 70% for the entire population, P = 0.0007), which was more apparent in the studies with contractile reserve defined as increase in LVEF (I 2 = 83%, P = 0.0006) compared with the subgroup with contractile reserve defined as increased contractility (I 2 = 44%, P = 0.13).
To evaluate possible causes for the heterogeneity observed, we performed meta-regression based on differences in baseline characteristics including year of publication, total number of patients, follow-up time, gender, age, ischaemic aetiology, LVEF, LVESV, QRS duration, and medical therapy, but could not find statistically significant modifiers of the association between contractile reserve and CRT response. In addition, in meta-regression analysis, the maximum dose of dobutamine used in the different studies did not significantly impact the overall results.
. 
Publication bias
There was evidence of publication bias on the visual assessment of the funnel plot as it demonstrated asymmetry (see the Supplementary material online for funnel plot, Figure S1 ). This finding was supported by results from the Begg adjusted-rank correlation test (P = 0.029), while the Egger test showed only a trend (P = 0.089).
Results from Metatrim suggested that at least four studies with neutral/negative effects of contractile reserve with CRT response were missing. Imputation of these (virtual) studies attenuated the association to some extent, but the positive association between contractile reserve and CRT response remained (OR 2.42, 95% CI 1.17-5.05, P = 0.018). 
Predictors of presence of contractile reserve
Current literature about contractile reserve is relatively limited and, as evident in our meta-analysis, different definitions are used to determine the presence of contractile reserve. The question remains whether there is a point from which a response to CRT is either likely or not likely, when one can actually speak of contractile reserve, and what predicts presence or absence of contractile reserve. Only one study looked at factors that were independently associated with contractile reserve presence in patients receiving CRT. 20 A total of 271 CRT candidates were studied, of whom 77% had an absolute increase in LVEF >5% with respect to baseline, which was considered as contractile reserve presence. Ventricular volumes, previous atrial arrhythmia history, and severe mitral regurgitation were significantly associated with the presence of contractile reserve. In the multivariate analysis only LV end-diastolic volume (per 10 mL variation) was able to predict contractile reserve presence (OR 0.93, 95% CI 0.99-1.00, P = 0.004).
The importance of regional myocardial viability has been investigated in several trials showing that preserved contractile reserve in the region where the LV-pacing lead is inserted is required in order to ensure efficient mechanical resynchronization. reserve or multimodality imaging-guided LV lead placement to the latest mechanically activated non-scarred myocardial LV segment, as a guide for CRT implantation, can be useful to increase response rate.
22,23
Ischaemic vs. non-ischaemic
The presence of contractile reserve seems to be independent of HF aetiology. Three studies in the current meta-analysis found that patients with ischaemic and non-ischaemic cardiomyopathy did not show any significant differences in the proportion of patients with contractile reserve. 7, 8, 20 Furthermore, in the meta-regression, ischaemic aetiology was not a statistically significant modifier of the association between contractile reserve and CRT response. This suggests that the myocardium per se has lost its ability to increase contractility because of intrinsic metabolic and/or ultrastructural alterations. Either way, testing contractile reserve seems an attractive technique to ensure that response can be achieved in patients with a non-ischaemic aetiology who are presumed to have a high response rate.
Dyssynchrony
Absence of contractile reserve seems to be able to identify 'sicker' patients who will not benefit from CRT. Some studies even suggest that contractile reserve seems a stronger predictor of response and provides incremental value beyond measurements of dyssynchrony. 6 Currently, no echocardiographic measures of dyssynchrony have been proven to reliably predict response to CRT. 24 However, mechanical dyssynchrony will likely not only be caused by conduction disturbances, but also by other myocardial wall properties, such as perfusion and viability. Dobutamine-induced LV contractility may uncover dyssynchrony and improve the predictive value of dyssynchrony parameters. Parsai et al. 25 were able to reveal LBBB-induced dyssynchronous motion during DSE and relate the degree of echocardiographic response after CRT with the presence of an abnormal septal motion during isovolumetric contraction (r = 0.6, P < 0.0001). DSE may reduce LV wall stress by vasodilatation and positive inotropic and chronotropic effects, thereby restoring ventricular septal myocardial perfusion. This may unmask the dyssynchronous motion caused by the underlying LBBB, and highlight the paradoxical septal motion, making dyssynchrony more easily detectable. Left ventricular dyssynchrony during exercise stress echocardiography, which provides a more physiological assessment of functional capacity, is also a strong predictor of CRT response. 26 It appears that in some potential responders dobutamineprovoked contractile reserve of the myocardium may predominantly increase dyssynchrony rather than contractility. The DSE-induced change in apical rocking amplitude, as a surrogate dyssynchrony parameter, has been found to have a strong negative correlation with ΔLVEF (r = −0.6, P < 0.001). Patients with the highest increase in apical rocking during the test had the highest decrease in LVESV during follow-up (r = −0.7, P < 0.001).
12 This study by Stankovic et al., 12 which was the only negative study in our meta-analysis, suggests that in CRT candidates with baseline dyssynchrony, myocardial contractile reserve may predominantly . 
Clinical implications
We theorize that DSE is able to detect patients that have residual viable tissue that can subsequently respond to electrical CRT stimulation by mechanistically mimicking resynchronization through recruiting cells that would not actively contract if not properly electrically stimulated. This highlights that attention should not only be given to electrical and mechanical dyssynchrony, but also to the myocardial substrate of functional response: that is, patients with little or no contractile reserve probably have an advanced disease process extending to the cellular level and seem less likely to respond to CRT. Estimating contractile reserve in patients with impaired LV function could possibly predict reversibility of the reduced contractile state and may aid in identifying optimal CRT candidates. However, it should be noted that absence of global contractile reserve does not automatically mean absence of CRT response. Patients should not be refused CRT implantation solely on the basis of the absence of contractile reserve as increasing dyssynchrony could prevent increasing contractility giving false-negative contractile reserve. Combining DSE with a measure of dyssynchrony could potentially increase specificity of this diagnostic test.
Only a handful of studies have investigated DSE and its utility in clinical practice. Applicability is challenging because of the timeand personnel-consuming nature of DSE. Nevertheless, DSE is a relatively inexpensive, useful, safe, non-invasive technique to assess contractile reserve. 27 Serious side-effects during or shortly after DSE are uncommon, especially considering that patients eligible for CRT are on optimal and maximally tolerated pharmacological therapy and revascularized if needed. Non-cardiac side-effects (nausea, headache, chills, urgency, and anxiety) are usually well tolerated, without the need for test termination. This makes DSE a good tool for the assessment of functional recovery. 27 Future studies should focus on other reliable physiological stress testing that is quick, easy, and less operator-dependent than DSE. Non-invasive cardiac output monitoring is an attractive target that could be combined with exercise regimes.
Study limitations
The studies included in the analysis were heterogeneous. However, this type of clinical heterogeneity is expected and the pooled data give an appropriate approximation of the average clinical population seeking CRT treatment, allowing generalizability of the results. All patients were candidates for CRT according to current guidelines. Data on clinical response was lacking in most studies and were therefore not included. Some methods for determining contractile reserve, such as analysis of segmental wall motion, are controversial and subject to variance in investigator interpretation. Nonetheless, these measures are routinely used in clinical practice for the detection of myocardial viability. Because we performed an aggregate meta-analysis, analyses using individual patient data were not possible. The prevalence of underlying LV dyssynchrony in the study populations, as well as baseline heart rate and possible underlying rhythm disorders, such as atrial fibrillation, could not be comprehensively collected and were therefore not included in the meta-regression. Furthermore, the funnel plot suggested that there was a small publication bias in our analysis, which may imply that the actual association could be slightly less pronounced, although, after correction, the association remained significant. In addition, we focused only on DSE and the follow-up of the studies included was relatively short.
Conclusion
The presence of global contractile reserve at baseline, as assessed by DSE, is associated with a higher chance of CRT response. This highlights the importance of the myocardial substrate, in addition to electrical and mechanical dyssynchrony, in HF patients receiving CRT.
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